If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Michele Bibas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma

Castillo, J. J., Guerrero-Garcia, T., Baldini, F., Tchernonog, E., Cartron, G., Ninkovic, S., Cwynarski, K., Dierickx, D., Tousseyn, T., Lansigan, F., Linnik, Y., Mogollon, R., Navarro, J-T., Olszewski, A. J., Reagan, J. L., Fedele, P., Gilbertson, M., Grigoriadis, G. & Bibas, M., 2018, In : British Journal of Haematology.

Research output: Contribution to journalArticle

  • Sickle Cell Disease

    Bibas, M., Jul 20 2017, In : New England Journal of Medicine. 377, 3, p. 303-304 2 p.

    Research output: Contribution to journalArticle

  • Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi-institutional retrospective study

    Castillo, J. J., Bower, M., Brühlmann, J., Novak, U., Furrer, H., Tanaka, P. Y., Besson, C., Montoto, S., Cwynarski, K., Abramson, J. S., Dalia, S., Bibas, M., Connors, J. M., Furman, M., Nguyen, M. L., Cooley, T. P., Beltran, B. E., Collins, J. A., Vose, J. M., Xicoy, B. & 1 others, Ribera, J. M., Feb 1 2015, In : Cancer. 121, 3, p. 423-431 9 p.

    Research output: Contribution to journalArticle